Browsing Tag
Oak Securities
3 posts
Poolbeg Pharma (AIM: POLB) raises £3.5m to fund POLB 001 and oral GLP-1 trials
The discounted placing should fund two potentially value-defining clinical studies through completion, although investors must absorb a larger share base before either programme produces proof-of-concept data.
Quantum Helium stock in focus as QHE confirms high-grade helium and oil at Sagebrush
Find out how Quantum Helium’s Sagebrush-1 test, 2.5% helium and surprise oil output could reshape QHE stock and Colorado resource upside.
Pri0r1ty Intelligence resumes trading as PR1 tests investor appetite for SME AI tools
Find out how Pri0r1ty Intelligence’s AIM return, first revenue and AI platform strategy are reshaping PR1 stock and SME technology sentiment.